[Clinical efficacies and safety of HAG regimen for patients with high-risk myelodysplastic syndromes: a multicentre study].
Lists
Only you see this
Abstract
HAG regimen provides higher CR rate and OR rate for patients with high-risk MDS.
BibTeX
@inproceedings{liu2012clinical,
author = {Hong Liu and Guangsheng He and Depei Wu and Aining Sun and Zonghong Shao and Sixuan Qian and Zhijian Xiao and Jun Ma and Shu-ye Wang and Xiao-Ping Xu and Ting Liu and Jie Jin and Zhichao Chen and Meiyun Fang and Baoan Chen and Lan‐Ping Xu and Zhixiang Shen and Changgeng Ruan},
title = {{[Clinical efficacies and safety of HAG regimen for patients with high-risk myelodysplastic syndromes: a multicentre study].}},
booktitle = {PubMed},
year = {2012},
}Loading related content...